Skip to main content
Ottobock SE & Co. KGaA logo

Ottobock SE & Co. KGaA — Investor Relations & Filings

Ticker · OBCK ISIN · DE000BCK2223 LEI · 529900LR96WLQ75KCE70 F Manufacturing
Open in API
Filings indexed 38 across all filing types
Latest filing 2026-05-13 M&A Activity
Country DE Germany
Listing F OBCK

About Ottobock SE & Co. KGaA

https://www.ottobock.com

Ottobock is a medical technology company that develops products and services to restore or improve human mobility. The company's core business areas are prosthetics, orthotics, and exoskeletons. In prosthetics, it is known for advanced mechatronic solutions, including microprocessor-controlled knee joints. The orthotics division offers devices for support, correction, and pain relief for individuals with injuries or neurological conditions. Ottobock also develops industrial exoskeletons designed to create more ergonomic workplaces and reduce physical strain in sectors like manufacturing and logistics. The company supports users through a global network of patient care centers, providing customized fitting, treatment, and rehabilitation services to cover the full treatment cycle.

Recent filings

Filing Released Lang Actions
Ottobock SE & Co. KGaA: Ottobock acquires patient care business from Blatchford in Norway for approximately 110 million
M&A Activity Classification · 87% confidence The document is an ad-hoc regulatory announcement disclosing inside information pursuant to MAR regarding Ottobock’s acquisition of Blatchford Norway’s patient care business for €110 million. This is a merger & acquisition transaction announcement, i.e., M&A Activity. There is no detailed financial report or share issuance, nor is it merely a publication notice. Therefore it falls under M&A Activity (TAR).
2026-05-13 English
Ottobock will be presenting innovative prosthetics and orthotics solutions at OTWorld 2026.
Regulatory Filings Classification · 92% confidence The document is a corporate press release announcing product presentations at a trade fair (OTWorld 2026). It contains no financial figures, voting or regulatory details, nor is it an earnings release, report, or presentation for investors. It is a general corporate news announcement, which falls under the fallback category for miscellaneous regulatory announcements and press releases.
2026-05-11 English
Ottobock continues growth trajectory with significant margin increase
Regulatory Filings
2026-05-06 English
Q1 Presentation
Investor Presentation
2026-05-06 English
Q1 statement / Q1 financial report 2026
Interim / Quarterly Report Q1 2026
2026-05-06 English
World Intellectual Property Day: Ottobock builds on its leadership in innovation.
Regulatory Filings Classification · 85% confidence The document is a corporate press release (EQS Media Release) announcing achievements in intellectual property and patents, not containing financial results, voting, legal updates, or actual regulatory filings like 10-K or IR. It does not fit into dividend notices, management changes, capital changes, or investor presentations. It is a general news/press announcement, which falls under the fallback category “Regulatory Filings” (RNS).
2026-04-23 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.